SlidesetHIVInternational Workshop on Aging & HIV 2017The biology of superagers- Nir Barzilai, MDView Slideset
JSJing SunMD, MPH, PhDSlidesetHIVInternational Workshop on Aging & HIV 2017Mitochondrial DNA variation associated with gait speed decline among older HIV-infected non-Hispanic white males- Jing SunView Slideset
SlidesetHIVInternational Workshop on Aging & HIV 2017Clinical Trials Targeting Aging to Extend Healthy Lifespan- Jamie Justice, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017PK and PKPD considerations for dose selection in the development of pembrolizumab | Dinesh de Alwis, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimensView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Clinical case discussions | Nielka van Erp, PharmD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanomaView Slideset
MRMark RatainMDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Opening Lecture: Inter- and intravariability in PK | Mark Ratain, MDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Physiologically based PK model vs. Population PK approach during drug development | Italo Poggesi, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Model-based TDM for oncology drugs | Ron Keizer, PharmD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancerView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017Assessment of the release of daunorubicin from liposomes after administration of daunoXome® using population pharmacokineticsView Slideset
